• Protocols

• LUNGMAP

  OPEN TO ACCRUAL

  A Master Protocol to Evaluate Biomarker-Driven Therapies & Immunotherapies in Previously-Tx'd NSCLC
  
  

• S1800E

  OPEN TO ACCRUAL

  Ph II/III Study of Docetaxel and Ramucirumab +/- Cemiplimabfor Participants wtih NSCLC